翰宇药业：关于董事兼高级管理人员退休离任的公告

Core Viewpoint - The announcement from Hanyu Pharmaceutical indicates that the company's Executive Director and CEO, Pinxiang Yu, has submitted her retirement application due to reaching the retirement age, effective immediately upon delivery to the board [2]. Group 1 - Pinxiang Yu will resign from her positions as both Executive Director and CEO of Hanyu Pharmaceutical, with her term originally set to last until the end of the sixth board's term [2]. - After her resignation, Pinxiang Yu will no longer hold any positions within the company or its subsidiaries [2].